CellCentric Company
CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2003
Employees Number:
1-10
Funding Status:
N/A
Investors Number:
9
Total Funding:
$42.6M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership